Alerts will be sent to your verified email
Verify Email
BACPHAR
|
Bacil Pharma
|
Shanmuga Hospital
|
Mangalam Drugs&Org.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-69.0 % | 44.19 % | -0.44 % |
|
5yr average Equity Multiplier
|
1.36 | 1.69 | 2.43 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 1.83 | 1.0 |
|
5yr Avg Net Profit Margin
|
0.0 | 13.07 % | 0.0 |
|
Price to Book
|
2.16 | 1.31 | 0.45 |
|
P/E
|
90.27 | 12.46 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | -11.46 Days | 17.41 Days |
|
Inventory Days
|
0.0 | 13.93 Days | 132.58 Days |
|
Days Receivable
|
0.0 | 59.96 Days | 38.43 Days |
|
Days Payable
|
0.0 | 51.52 Days | 126.53 Days |
|
5yr Average Interest Coverage Ratio
|
-943.72 | 80.15 | 0.9 |
|
5yr Avg ROCE
|
-75.56 % | 54.92 % | 6.92 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 20.54 % | 7.63 % |
|
5 yr average Debt to Equity
|
0.05 | 0.34 | 0.59 |
|
5yr CAGR Net Profit
|
n/a | -8.93 % | 39.54 % |
|
5yr Average Return on Assets
|
-70.2 % | 26.81 % | -0.18 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.08 % | 72.06 % | 35.64 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 7.09 % |
|
Change in Promoter Holding (3 Yrs)
|
-42.59 % | 0.11 % | -14.68 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bacil Pharma
|
Shanmuga Hospital
|
Mangalam Drugs&Org.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|